Institution
Research Institute of the McGill University Health Centre
Also known as: Institut de recherche du Centre universitaire de santé McGill · RI-MUHC
- 38running trials
- 17closed trials
- 1researcher
- 11,512publications (OpenAlex)
Researchers
Running trials
Not yet recruiting
Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism
Recruiting
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Recruiting
People With Osteoporosis Can Walk-BEST to Reduce Fall and Fracture Risk
Recruiting
Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
Recruiting
Recruiting
Recruiting
Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure
Recruiting
Recruiting
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Recruiting
Recruiting
Recruiting
COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Active, not recruiting
Active, not recruiting
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Active, not recruiting
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Not yet recruiting
The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Active, not recruiting
Active, not recruiting
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
Recruiting
Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Active, not recruiting
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Heart failure2 recruiting
- HIV2 recruiting
- Type 1 diabetes2 recruiting
- Bladder cancer1 recruiting
- Chronic kidney disease1 recruiting
- Chronic spontaneous urticaria1 recruiting
- Colorectal cancer1 recruiting
- COPD1 recruiting
- Deep vein thrombosis and pulmonary embolism1 recruiting
- Epilepsy1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Glioblastoma1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Kidney cancer1 recruiting
- Lewy body dementia1 recruiting
- Lung cancer1 recruiting
- Multiple system atrophy1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Osteoporosis1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Parkinson disease1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoma1 recruiting
- Thyroid cancer1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Terminated
Effect of Artificial Sweetener (AFS) on Glucose Metabolism in Patients With Type 1 Diabetes (T1D)
Completed
Withdrawn
Completed
Evaluating the Efficacy of a Mobile Epilepsy Education Application
Completed
Completed
Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
Completed
Virtual Physical Rehabilitation for Patients Living with Long COVID
Completed
Terminated
Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung Disease
Completed
Completed
Recruiting
Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes
Completed
Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
Completed
Terminated
Completed
Registry name variants (17)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Research Institute of the McGill University Health Centre
Montreal, Quebec H3G 1A4
14 trials
The Research Institute of the McGill University Health Centre
Montreal, Quebec H3H 2R9
12 trials
McGill University Health Center - Research Institute
Montreal, H4A 3J1
4 trials
McGill University Health Centre Research Institute
Montreal, Quebec H4A 3J1
4 trials
Research Institute-McGill University Health Center
Montreal, Quebec H4A 3J1
4 trials
Research Institute, McGill University Health Centre
Montreal, Quebec H4A 3S5
3 trials
Contact: Clinical Trials Administrator
NCT05298878Virtual Physical Rehabilitation for Patients Living with Long COVID
Research Institute of McGill University Health Centre
Montreal, Quebec H4A 3J1
2 trials
NCT07659106Decision Aid for Anticoagulation Duration After Unprovoked Venous Thromboembolism
Contact: Sidra Ahmed
NCT06599658COVID-19 Booster and IIV Schedule in Immunocompromised Hosts
Contact: Ruth Sapir-Pichhadze, B.Med.Sc., MD, MSc, PhD, FRCPC
RI-MUHC
Montreal, Quebec H4A 3J1
2 trials
The Research Institute of McGill University Health Centre
Montreal, Quebec City H3H 2R9
2 trials
NCT05204888myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Contact: Francine Noel
NCT03626038Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
The Research Institute of the McGill University Health Center
Montreal, Quebec H3G 1A4
2 trials
Contact: Talat Bessissow (principal investigator)
Center for Innovative Medicine, The Research Institute of the McGill University Health Centre
Montreal, Quebec H4A 3J1
1 trial
McGill University Health Center Research Institute
Montreal, Quebec H4A 3J1
1 trial
McGill University Health Center Research Institute
Montreal, Quebec H4A 3J1
1 trial
McGill University Health Center - Research Institute (Site 0114)
Montreal, Quebec H4A 3J1
1 trial
McGill University, The Research Institute of the McGill University Health Center
Montreal, Quebec H4A 3J1
1 trial
Research Institute of the McGill University Health Center
Montreal, Quebec
1 trial
NCT05305495Empagliflozin in Acute Heart Failure
The Research Institute of the McGill University Health Centre (RI-MUHC)
Montreal, Quebec H3H 2R9
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Ovarian cancer28 works · 1 trial
- Endometrial cancer24 works · 0 trials
- COPD23 works · 2 trials
- Lupus (SLE)22 works · 0 trials
- Systemic sclerosis (scleroderma)13 works · 1 trial
- Hepatitis C11 works · 0 trials
- Familial hypercholesterolaemia8 works · 0 trials
- Duchenne muscular dystrophy7 works · 1 trial
- Nephrotic syndrome7 works · 0 trials
- Uterine fibroids4 works · 0 trials
Institution data: ROR 04pemf943 (CC0-1.0)Updated 15 Nov 2026